Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2022 | Safety & efficacy of TPO-RAs in elderly patients with ITP

Priyanka Raheja, MBBS, MD, Royal London Hospital, London, UK, briefly discusses the results of a real-world study of the UK adult immune thrombocytopenia (ITP) registry investigating the safety and efficacy of thrombopoietin receptor agonists (TPO-RAs) in older patients with primary ITP. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.

Disclosures

Consultant: Pfizer, Sobi, Idogen, Takeda